healthcare
EU Drugs Regulator Backs Higher Dose of Novo's Wegovy
King Charles Shares 'good News' of Reduced Cancer Treatment in Tv Address
EU Seals Pact to Overhaul Drug Rules, Speed Patient Access
HeadlinesUK Hospitals Facing 'worst Case Scenario' From Super Flu, Doctors Warn
Zealand Pharma Seeks to Challenge GLP‑1 Dominance With Obesity Drug Aimed at Long‑term Use
Date: December 11, 2025
LONDON, Dec 11 (Reuters) - Danish biotech Zealand Pharma said on Thursday it will accelerate development and expand its research as it seeks to differentiate its experimental obesity drug candidates...
UK Medicine Rebate Rate to Drop in 2026 After US Pharma Deal
Date: December 10, 2025
By Alistair Smout LONDON, Dec 10 (Reuters) - The British government said on Wednesday that the proportion of revenues from new medicine sales pharmaceutical firms need to pay back into England's...
Hims and Hers to Offer Weight-Loss Treatments in UK
Date: December 10, 2025
NEW YORK, Dec 10 (Reuters) - Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United Kingdom which will include drugs like Novo...
'Shockingly High' Number of Gaza Children Still Acutely Malnourished After Truce, UN Says
Date: December 9, 2025
GENEVA, Dec 9 (Reuters) - Thousands of children have been admitted for treatment for acute malnutrition in Gaza since an October ceasefire that was supposed to enable a major increase in humanitarian...
Exclusive-US Fda Launches Fresh Safety Scrutiny of Approved Rsv Therapies for Infants
Date: December 9, 2025
By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for...
Factbox-How Hedge Funds Performed in a Volatile November
Date: December 3, 2025
By Nell Mackenzie and Anirban Sen LONDON, Dec 3 (Reuters) - Global hedge funds, including stock pickers, have generated returns of nearly 15% in 2025 to the end of November, according to a Goldman...